Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-07

Clinical Trial Update: Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated tacrolimus for treating primary nephrotic syndrome in children; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Nephrotic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2019-02-07